Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture

5 (1 vote)

Recorded On: 11/12/2018

Patients with underlying chronic liver disease (CLD) may develop drug-induced liver injury during clinical care or in clinical trials, and it is associated with poor outcomes. This lecture discusses medications and herbal agents that are commonly implicated in DILI, risk factors, strategies for  monitoring patients in clinical trials, guidelines for adjudicating suspected DILI events and outcomes associated with DILI in CLD.

Raymond T. Chung (Moderator)

Naga P. Chalasani


DILI in Chronic Liver Disease – The Next Major Hurdle
Open to view video.
Open to view video. Moderator: Raymond Chung Presenter: Naga Chalasani
Final Evaluation
Final Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.